New drugs, or new trials of current drugs, for the treatment of acute ischaemic stroke?

Detalles Bibliográficos
Publicado en:Lancet Vol. 358; no. 9283; pp. 683 - 685
Autores principales: Hankey, Graeme J, Hankey, G J
Formato: commentary Journal Article
Publicado: Lancet 9/1/2001
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=5090618&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 5090618
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 9/1/2001
      vid: 358
      iid: 9283
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        5090618
        5090618
        NLM11551570
        5090618
        10.1016/S0140-6736(01)05847-0
        NLM11551570
        5090618
      ppf: 683
      ppct: 2
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: New drugs, or new trials of current drugs, for the treatment of acute ischaemic stroke?
      aug:
        au:
          Hankey, Graeme J
          Hankey, G J
        affil: Department of Neurology, Royal Perth Hospital, WA 6001, Perth, Australia
      sug:
        subj:
          Heparin, Low-Molecular-Weight Therapeutic Use
          Stroke Drug Therapy
          Aspirin Therapeutic Use
          Fibrinolytic Agents Therapeutic Use
      pubtype: Academic Journal
      doctype:
        commentary
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N